Runx3 regulates integrin αE/CD103 and CD4 expression during development of CD4-/CD8+ T cells

Journal of Immunology

Volumn 175, Issue 3, 2005, Pages 1694-1705

  Grueter, Baerbel ^a,e   Petter, Michaela ^b,f   Egawa, Takeshi ^d   Laule Kilian, Kirsten ^b,g   Aldrian, Christine J ^b   Wuerch, Andreas ^b   Ludwig, Yvonne ^a,h   Fukuyama, Hidehiro ^c   Wardemann, Hedda ^c   Waldschuetz, Ralph ^a   Möröy, Tarik ^a   Taniuchi, Ichiro ^d,i   Steimle, Viktor ^b,j   Littman, Dan R ^d   Ehlers, Marc ^a,b,c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c ROCKEFELLER UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e FORSCHUNGSZENTRUM JÜLICH   (Germany)

^f BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

^h UNIVERSITY OF MÜNSTER   (Germany)

ⁱ RIKEN Center for Integrative Medical Sciences   (Japan)

^j UNIVERSITÉ DE SHERBROOKE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; CD103 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTEGRIN ALPHAE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL FATE; CELL MATURATION; CELL TYPE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE; TRANSGENE;

EID: 22544451206     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.3.1694     Document Type: Article

References (67)

1. Starr, T. K., S. C. Jameson, and K. A. Hogquist. 2003. Positive and negative T cell selection. Annu. Rev. Immunol. 21: 139-176.
2. Germain, R. N. 2002. T-cell development and the CD4-CD8 lineage decision. Nat. Rev. Immunol. 1: 309-322.
3. Bendelac, A., P. Matzinger, R. A. Seder, W. E. Paul, and R. H. Schwartz. 1992. Activation events during thymic selection. J. Exp. Med. 175: 731-742.
4. + thymocyte differentiation. Immunity 5: 461-477.
5. Hedrick, S. M. 2002. T cell development: bottoms-up. Immunity 16: 619-622.
6. Bosselut, R. 2004. CD4/CD8-lineage differentiation in the thymus: from nuclear effectors to membrane signals. Nat. Rev. Immunol. 4: 529-540.
7. Taniuchi, I., M. Osato, T. Egawa, M. J. Sunshine, S. C. Bae, T. Komori, Y. Ito, and D. R. Littman. 2002. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111: 621-633.
8. Woolf, E., C. Xiao, O. Fainaru, J. Lotem, D. Rosen, V. Negreanu, Y. Bernstein, D. Goldenberg, O. Brenner, G. Berke, et al. 2003. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc. Natl. Acad. Sci. USA 100: 7731-7736.
9. + thymocytes. J. Immunol. 171: 3594-3604.
10. Lutterbach, B., and S. W. Hiebert. 2000. Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Gene 245: 223-235.
11. Levanon, D., V. Negreanu, Y. Bernstein, I. Bar-Am, L. Avivi, and Y. Groner. 1994. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localisation. Genomics 23: 425-432.
12. Levanon, D., Y. Bernstein, V. Negreanu, M. C. Ghozi, I. Bar-Am, R. Aloya, D. Goldenberg, J. Lotem, and Y. Groner. 1996. A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. DNA Cell Biol. 15: 175-185.
13. Le, X.-F., Y. Groner, S. M. Kornblau, Y. Gu, W. N. Hittelman, D. Levanon, K. Mehta, R. B. Arlinghaus, and K.-S. Chang. 1999. Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor α-dependent signaling pathway. J. Biol. Chem. 274: 21651-21658.
14. Li, Q. L., K. Ito, C. Sakakura, H. Fukamachi, K. Inoue, X. Z. Chi, K. Y. Lee, S. Nomura, C. W. Lee, S. B. Han, et al. 2002. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109: 113-124.
15. Prokunina, L., C. Castillejo-Lopez, F. Oberg, I. Gunnarsson, L. Berg, V. Magnusson, A. J. Brookes, D. Tentler, H. Kristjansdottir, G. Grondal, et al. 2002. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32: 666-669.
16. Helms, C., L. Cao, J. G. Krueger, E. M. Wijsman, F. Chamian, D. Gordon, M. Heffernan, J. A. Daw, J. Robarge, J. Ott, et al. 2003. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat. Genet. 35: 349-356.
17. Tokuhiro, S., R. Yamada, X. Chang, A. Suzuki, Y. Kochi, T. Sawada, M. Suzuki, M. Nagasaki, M. Ohtsuki, M. Ono, et al. 2003. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35: 341-348.
18. Nielsen C., D. Hansen, S. Husby, B. B. Jacobsen, and S. T. Lillevang. 2003. Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 62: 492-497.
19. Shi, M. J., and J. Stavnezer. 1998. CBFα3 (AML2) is induced by TGF-β1 to bind and activate the mouse germline Ig α promoter. J. Immunol. 161: 6751-6760.
20. Levanon, D., D. Bettoun, C. Harris-Cerruti, E. Woolf, V. Negreanu, R. Eilam, Y. Bernstein, D. Goldenberg, C. Xiao, M. Fliegauf, et al. 2002. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 21: 3454-3463.
21. Fainaru, O., E. Woolf, J., Lotem, M. Yarmus, O. Brenner, D. Goldenberg, V. Negreanu, Y. Bernstein, D. Levanon, S. Jung, et al. 2004. Runx3 regulates mouse TGF-β-mediated dendritic cell function and its absence results in airway inflammation. EMBO J. 23: 969-979.
22. Hanai, J., L. F. Chen, T. Kanno, N. Ohtani-Fujita, W. Y. Kim, W. H. Guo, T. Imamura, Y. Ishidou, M. Fukuchi, M. J. Shi, et al. 1999. Interaction and functional cooperation of PEBP2/CBF with Smads: synergistic induction of the immunoglobulin germline Cα promoter. J. Biol. Chem. 274: 31577-31582.
23. Yoshida, C. A., H. Yamamoto, T. Fujita, T. Furuichi, K. Ito, K. Inoue, K. Yamana, A. Zanma, K. Takada, Y. Ito, et al. 2004. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev. 18: 952-963.
24. Ito, Y. 1999. Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF. Genes Cells 4: 685-696.
25. Duncan, D. D., M. Adlam, and G. Siu. 1996. Asymmetric redundancy in CD4 silencer function. Immunity 4: 301-311.
26. Leung, R. K., K. Thomson, A. Gallimore, E. Jones, M. Van den Broek, S. Sierro, A. R. Alsheikhly, A. McMichael, and A. Rahemtulla. 2001. Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment. Nat. Immunol. 2: 1167-1173.
27. Siu, G., A. L. Wurster, D. D. Duncan, T. M. Soliman, and S. M. Hedrick. 1994. A transcriptional silencer controls the developmental expression of the CD4 gene. EMBO J. 13: 3570-3579.
28. Sawada, S., J. D. Scarborough, N. Killeen, and D. R. Littman. 1994. A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development. Cell 77: 917-929.
29. Taniuchi, I., M. J. Sunshine, R. Festenstein, and D. R. Littman. 2002. Evidence for distinct CD4 silencer functions at different stages of thymocyte differentiation. Mol. Cell 10: 1083-1096.
30. Allen, R. D., III, T. P. Bender, and G. Siu. 1999. c-Myb is essential for early T cell development. Genes Dev. 13: 1073-1078.
31. Ellmeier, W., S. Sawada, and D. R. Littman. 1999. The regulation of CD4 and CD8 coreceptor gene expression during T cell development. Annu. Rev. Immunol. 17: 523-554.
32. Kim, H. K., and G. Siu. 1998. The Notch pathway intermediate HES-1 silences CD4 gene expression. Mol. Cell. Biol. 18: 7166-7175.
33. Kim, W. W. S., and G. Siu. 1999. Subclass-specific nuclear localization of a novel CD4 silencer binding factor. J. Exp. Med. 190: 281-292.
34. Allen, R. D., III, H. K. Kim, S. D. Sarafova, and G. Siu. 2001. Negative regulation of CD4 gene expression bv a hes-1-c-myb complex. Mol. Cell. Biol. 21: 3071-3082.
35. E (CD103)-deficient mice. J. Immunol. 162: 6641-6649.
36. Bangsow, C., N. Rubins, G. Glusman, Y. Bernstein, V. Negreanu, D. Goldenberg, J. Lotem, E. Ben-Asher, D. Lancet, D. Levanon, et al. 2001. The RUNX3 gene: sequence, structure and regulated expression. Gene 279: 221-232.
37. Schmidt, T., H. Karsunky, E. Gau, B. Zevnik, H. P. Elsasser, and T. Moroy. 1998. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. Oncogens 17: 2661-2667.
38. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Plainview.
39. + cells but markedly decreased helper cell activity in mice lacking CD4. Nature 353: 180-184.
40. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice ccnstructed using cDNA-based β- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell. Biol. 76: 34-40.
41. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Sevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
42. Bettelli, E., M. Pagany, H. L. Weiner, C. Linington, R. A. Sobel, and V. K. Kuchroo. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197: 1073-1081.
43. Kanto, S., N. Chiba, Y. Tanaka, S. Fujita, M. Endo, N. Kamada, K. Yoshikawa, A. Fukuzaki, S. Orikasa, T. Watanabe, and M. Satake. 2000. The PEBP2β/CBF β-SMMHC chimeric protein is localized both in the cell membrane and nuclear subfractions of leukemic cells carrying chromosomal inversion 16. Leukemia 14: 1253-1259.
44. Hayashi, K., N. Abe, T. Watanabe, M. Obinata, M. Ito, T. Sato, S. Habu, and M. Satake. 2001. Overexpression of AML1 transcription factor drives thymocytes into the CD8 single-positive lineage. J. Immunol. 167: 4957-4965.
45. Tyznik, A. J., J. C. Sun, and M. J. Bevan. 2004. The CD8 population in CD4-deficient mice is heavily contaminated with MHC class II-restricted T cells. J. Exp. Med. 199: 559-565.
46. + thymocytes lead to enhanced thymocyte cell proliferation. J. Cell Sci. 115: 4505-4515.
47. McFarland, R. D., D. C. Douek, R. A. Koup, and L. J. Picker. 2000. Identification of a human recent thymic emigrant phenotype. Proc. Natl. Acad. Sci. USA 97: 4215-4220.
48. 7 (CD103). Immunology 103: 146-154.
49. + regulatory T cells. J. Exp. Med. 199: 303-313.
50. + T cells. Immunity 13: 59-71.
51. Telfer, J. C., E. E. Hedblom, M. K. Anderson, M. N. Laurent, and E. V. Rothenberg. 2004. Localization of the domains in runx transcription factors required for the repression of CD4 in thymocytes. J. Immunol. 172: 4359-4370.
52. Kohu, K., T. Sato, S. Ohno, K. Hayashi, R. Uchino, N. Abe, M. Nakazato, N. Yoshida, T. Kikuchi, Y. Iwakura, et al. 2005. Overexpression of the runx3 transcription factor increases the proportion of mature thymocytes of the CDS single-positive lineage. J. Immunol. 174: 2627-2636.
53. Spender, L. C., G. H. Cornish, A. Sullivan, and P. J. Farrell. 2002. Expression of transcription factor AML-2 (RUNX3, CBF(α)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. J. Virol. 76: 4919-4927.
54. Spender, L. C., H. J. Whiteman, C. E. Karstegl, and P. J. Farrell. 2005. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells. Oncogene 24: 1873-1881.
55. Zou, Y.-R., M.-J. Sunshine, I. Tamuchi, F. Hatam, N. Killeen, and D. R. Littman. 2001. Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage. Nat. Genet. 29: 332-336.
56. Singer, A. 2002. New perspectives on a developmental dilemma: the kinetic signaling model and the importance of signal duration for the CD4/CD8 lineage decision. Curr. Opin. Immunol. 14: 207-215.
57. Sato, T., S. Ohno, T. Hayashi, C. Sato, K. Kohu, M. Satake, and S. Habu. 2005. Dual functions of runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes. Immunity 22: 317-328.
58. He, X., X. He, V. P. Dave, Y. Zhang, X. Hua, E. Nicolas, W. Xu, B. A. Roe, and D. J. Kappes. 2005. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature 433: 826-833.
59. Sun, G., X. Liu, P. Mercado, S. R. Jenkinson, M. Kypriotou, L. Feigenbaum, P. Galera, and R. Bosselut. 2005. The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat. Immunol. 6: 373-381.
60. 7 expression by transforming growth factor-β. Int. Immunol. 14: 339-345.
61. - regulatory T cells. Proc. Natl. Acad. Sci. USA 99: 13031-13036.
62. + CTL. J. Immunol. 159: 3748-3756.
63. + T cells. J. Exp. Med. 196: 877-886.
64. + T cells responding to renal allografts. J. Immunol. 172: 214-221.
65. Annels, N. E., A. J. Willemze, V. H. van der Velden, C. M. Faaij, E. van Wering, D. M. Sie-Go, R. M. Egeler, M. J. van Tol, and T. Revesz. 2004. Possible link between unique chemokine and homing receptor expression at diagnosis and relapse location in a patient with childhood T-ALL. Blood 103: 2806-2808.
66. Zhang, Y., and R. Derynck. 2000. Transcriptional regulation of the transforming growth factor-β-inducible mouse germ line Ig α constant region gene by functional cooperation of Smad, CREB, and AML family members. J. Biol. Chem. 275: 16979-16985.
67. Egawa, T., G. Eberl, I. Taniuchi, K. Benlagha, F. Geissmann, L. Hennighausen, A. Bendelac, and D. R. Littman. 2005. Genetic evidence supporting selection of the Val 4i NKT cell lineage from double positive thymocyte precursors. Immunity In Press.